Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) Insider Sells 125,000 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Patrick Cunningham sold 125,000 shares of the company’s stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total value of $948,750.00. Following the completion of the transaction, the insider directly owned 212,755 shares of the company’s stock, valued at approximately $1,614,810.45. This trade represents a 37.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Aveanna Healthcare Price Performance

Shares of NASDAQ AVAH traded down $0.01 during mid-day trading on Thursday, reaching $7.67. The company’s stock had a trading volume of 1,003,505 shares, compared to its average volume of 1,313,309. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The firm has a market capitalization of $1.67 billion, a PE ratio of 6.50, a P/E/G ratio of 0.91 and a beta of 1.93. The stock has a fifty day moving average of $6.74 and a two-hundred day moving average of $7.87.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm had revenue of $647.92 million for the quarter, compared to analysts’ expectations of $613.22 million. The company’s revenue was up 15.9% on a year-over-year basis. As a group, sell-side analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.56 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. BMO Capital Markets decreased their price target on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday, March 20th. Weiss Ratings downgraded shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, April 6th. Royal Bank Of Canada increased their price objective on Aveanna Healthcare from $9.00 to $10.00 and gave the company a “sector perform” rating in a report on Friday, May 15th. Truist Financial raised their price objective on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research note on Wednesday. Finally, Barclays lowered their price target on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a report on Monday. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, Aveanna Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $10.50.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Bank of America Corp DE boosted its position in Aveanna Healthcare by 64.2% in the 1st quarter. Bank of America Corp DE now owns 402,510 shares of the company’s stock valued at $2,592,000 after buying an additional 157,368 shares during the period. Smith Group Asset Management LLC boosted its holdings in Aveanna Healthcare by 34.3% in the first quarter. Smith Group Asset Management LLC now owns 263,669 shares of the company’s stock valued at $1,698,000 after purchasing an additional 67,393 shares during the period. EverSource Wealth Advisors LLC grew its stake in Aveanna Healthcare by 22.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 17,552 shares of the company’s stock worth $113,000 after purchasing an additional 3,172 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in Aveanna Healthcare by 56.3% during the 1st quarter. The Manufacturers Life Insurance Company now owns 36,509 shares of the company’s stock worth $235,000 after purchasing an additional 13,155 shares during the period. Finally, Quantinno Capital Management LP purchased a new stake in Aveanna Healthcare during the 1st quarter worth about $111,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.